| 1 |
Nair S, Wilding JP. Sodium glucose cotransporter 2 inhibitors as a new treatment for diabetes mellitus. J Clin Endocrinol Metab. 2010; 95(1):34-42.
doi: 10.1210/jc.2009-0473
|
| 2 |
Reed J. Impact of sodium-glucose cotransporter 2 inhibitors on blood pressure. Vasc Heal Risk Manag. 2016; 12:393-405.
|
| 3 |
Filippas-Ntekouan S, Filippatos TD, Elisaf MS. SGLT2 inhibitors: are they safe? Postgrad Med. 2018; 130(1):72-82.
doi: 10.1080/00325481.2018.1394152
pmid: 29039237
|
| 4 |
Silverii GA, Monami M, Mannucci E. Sodium-glucose co-transporter-2 inhibitors and all-cause mortality: a meta-analysis of randomized controlled trials. Diabetes Obes Metab. 2021; 23(4):1052-6.
doi: 10.1111/dom.v23.4
|
| 5 |
Schaeffer SE, DesLauriers C, Spiller HA, Aleguas A, Baeza S, Ryan ML. Retrospective review of SGLT2 inhibitor exposures reported to 13 poison centers. Clin Toxicol (Phila). 2018; 56(3):204-8.
doi: 10.1080/15563650.2017.1357824
pmid: 28812381
|
| 6 |
Smith K, Gomez L, Smith L, Hein N, Kirschner R. How sweet it is: sodium glucose co-transporter 2 inhibitor ingestions reported to U.S. poison centers. 2017 North American Congress of Clinical Toxicology, Vancouver, Canada, 2017.
|
| 7 |
Kovacich N, Chavez B. Ertugliflozin (steglatro): a new option for SGLT2 inhibition. P T. 2018; 43(12):736-42.
|
| 8 |
Thieu VT, Mitchell BD, Varnado OJ, Frier BM. Treatment and prevention of severe hypoglycaemia in people with diabetes: Current and new formulations of glucagon. Diabetes Obes Metab. 2020; 22(4):469-79.
doi: 10.1111/dom.v22.4
|
| 9 |
Dalal R, Bruss ZS, Sehdev JS. Physiology, Renal Blood Flow and Filtration. [Updated 2021 Jul 26]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK482248/
|
| 10 |
Zhao LM, Zhang M, Zhan ZL, Qiu M. Does combination therapy with SGLT2 inhibitors and renin-angiotensin system blockers lead to greater reduction in cardiorenal events among patients with type 2 diabetes? Front Cardiovasc Med. 2021; 8:679124.
doi: 10.3389/fcvm.2021.679124
|
), Joshua Nogar
